SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026883
Filing Date
2022-05-16
Accepted
2022-05-16 12:49:23
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_bespoke.htm   iXBRL 10-Q 567549
2 CERTIFICATION f10q0322ex31-1_bespoke.htm EX-31.1 10049
3 CERTIFICATION f10q0322ex32-1_bespoke.htm EX-32.1 3938
  Complete submission text file 0001213900-22-026883.txt   3809435

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20220331.xsd EX-101.SCH 44749
5 XBRL CALCULATION FILE bspk-20220331_cal.xml EX-101.CAL 25193
6 XBRL DEFINITION FILE bspk-20220331_def.xml EX-101.DEF 227566
7 XBRL LABEL FILE bspk-20220331_lab.xml EX-101.LAB 424773
8 XBRL PRESENTATION FILE bspk-20220331_pre.xml EX-101.PRE 235064
49 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_bespoke_htm.xml XML 339784
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 22927215
SIC: 2834 Pharmaceutical Preparations